Dianthus Therapeutics DNTH
NASDAQ DNTH
$89.30 +0.49 (+0.55%)
At close: Nov 11, 2026 · 4:00 PM EST

Dianthus Therapeutics (DNTH) Long-Term Debt Issuances (2023)

Updated

Dianthus Therapeutics' Long-Term Debt Issuances came in at $377,000 for FY2023.

Analysis

Dianthus Therapeutics (DNTH) Long-Term Debt Issuances (2023) Analysis & Trends

  • The FY2023 figure represents the highest annual Long-Term Debt Issuances since FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Dianthus Therapeutics 5.00 Bn 4.95 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 377,000.00
API Access

Dianthus Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=DNTH&period=max&api_key=YOUR_API_KEY